| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9194520 | Journal of Neuroimmunology | 2005 | 10 Pages |
Abstract
Our observations suggest that the beneficial effects of mitoxantrone in MS result (i) from its immunosuppressive action based on nonspecific cytotoxic effects on lymphocytes, (ii) by inducing programmed cell death of professional APCs, such as DCs.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Oliver Neuhaus, Heinz Wiendl, Bernd C. Kieseier, Juan J. Archelos, Bernhard Hemmer, Olaf Stüve, Hans-Peter Hartung,